News
1d
Live Science on MSNOzempic-style drugs treat type 1 diabetes, not only type 2, study findsA clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.
In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
13d
Medical Device Network on MSNPharmaSens and SiBionics to develop wearable insulin patch pumpSwiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that ...
A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...
Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...
"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...
The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...
A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results